Cx43通过降低DNA修复能力来增强对BRAF/MEK抑制剂的反应
Adrián Varela-Vázquez1,2, Amanda Guitián-Caamaño1,3, Paula Carpintero-Fernández1
1CELLCOM Research Group. Biomedical Research Center (CINBIO) and Institute of Biomedical Research of Ourense-Pontevedra-Vigo (IBI), University of Vigo (Before: Instituto de Investigación Biomédica de A Coruña (INIBIC), Servizo Galego de Saúde (SERGAS), Universidade da Coruña (UDC), A Coruña, Spain), Pontevedra, Spain.
Nature communications
|July 4, 2025
概括
康尼辛43 (Cx43) 通过促进DNA损伤和衰老,增强了瘤中BRAF/MEK抑制剂的有效性. 这一发现导致了一种新的药物组合疗法,使用小细胞外囊泡 (sEV) 来克服治疗耐药性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- BRAF和MEK抑制剂 (BRAF/MEKi) 为BRAF突变瘤提供了改善的结果.
- 在BRAF/MEKi治疗中,有限的疗效和获得的耐药性仍然是重大挑战.
研究的目的:
- 调查Connexin43 (Cx43) 在调节对BRAF/MEKi治疗反应中的作用.
- 探索Cx43作为一种潜在的治疗点,以克服BRAF突变瘤中抗药性.
主要方法:
- 利用临床前癌症模型研究Cx43.3的影响.
- 研究了Cx43在DNA修复和细胞衰老中的机制.
- 开发了一种药物组合策略,涉及通过小细胞外囊泡 (sEV) 传递Cx43.
主要成果:
- Cx43通过招募DNA修复复合体并诱导持续的DNA损伤来增强BRAF/MEKi的有效性.
- 通过Cx43调解的核细分促进了基因组的不稳定性和合成致命性.
- 设计了一种与BRAF/MEKi一起提供Cx43的组合疗法.
结论:
- Cx43作为DNA修复和对BRAF/MEKi反应的关键调节剂.
- 基于Cx43的治疗策略显示出克服耐药性和改善晚期BRAF突变癌症的结果的潜力.
相关概念视频
DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
MAPK Signaling Cascades
6.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Interactions Between Signaling Pathways
6.5K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.5K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K


